Skip to main content
Signal8

Mun-Gavin David C.

SEC insider (Form 3/4/5 filer). CIK 0002078965. Director at GT Biopharma, Inc. (GTBP). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 4, 2025. Located in SAN FRANCISCO, CA.

Companies Mun-Gavin David C. has filed insider reports for

  • GT Biopharma, Inc. (GTBP): Director
Mun-Gavin David C. profile photo

Mun-Gavin David C.

CIK: 0002078965

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GT Biopharma, Inc. logo
GTBP

GT Biopharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • GT Biopharma, Inc. logo
    GTBP

    GT Biopharma, Inc.

    Sep 4, 2025
    Award

    Option to purchase Common Stock

    Direct
    31.3K shares-

1-1 of 1